YGR160W Antibody

What is YGR160W and why are antibodies against it important for yeast genetics research?

YGR160W is the systematic name for the SRS2 gene in Saccharomyces cerevisiae. The SRS2 gene encodes a 3' to 5' DNA helicase originally identified as a suppressor of the ultraviolet sensitivity of rad6 and rad18 mutations, and independently identified as a hyper-recombination mutant (hpr5) . Antibodies against YGR160W/Srs2 are essential research tools because they enable:

• Tracking of Srs2 protein localization during various cellular processes

• Investigation of protein-protein interactions involving Srs2

• Examination of Srs2's multiple roles in DNA repair, recombination, and replication

• Analysis of how Srs2 contributes to genome stability

• Study of post-translational modifications that regulate Srs2 function

Srs2 is particularly significant due to its role as an "anti-recombinase" - it can dismantle Rad51 filaments which are required for homologous recombination to occur . Additionally, Srs2 is recruited to replication forks by SUMOylated PCNA to prevent inappropriate recombination during DNA replication .

What are the most effective protein extraction methods for detecting YGR160W in Western blots?

For effective detection of YGR160W/Srs2 in Western blots, researchers should consider these optimized extraction protocols:

NaOH/TCA Precipitation Method:

• Resuspend cell pellets in 100 μl of cold 1.85 N NaOH with 7.5% 2-mercaptoethanol

• Incubate for 10 minutes on ice

• Precipitate proteins with 30 μl of cold 50% Trichloroacetic acid (TCA)

• Incubate for 10 minutes on ice, then centrifuge (5 min, 4°C, maximum speed)

• Resuspend precipitates in buffer containing 40 mM Tris pH 6.8, 8 M Urea, 5% SDS, 0.1 mM EDTA, and 7.5% 2-mercaptoethanol

For Native Protein Extractions:

• Dilute overnight cell cultures and allow 2-hour growth period

• Use gentle lysis methods to preserve protein-protein interactions

For gel electrophoresis and detection:

• Use 6% SDS-PAGE gels specifically for visualizing Srs2

• Transfer at 25V in buffer containing 12 mM Tris, 100 mM Glycine, and 20% ethanol

This approach is highly effective for nuclear proteins like Srs2, which can otherwise be difficult to extract and detect due to their relatively low abundance and nuclear localization.

How can researchers validate the specificity of YGR160W antibodies?

Validation of YGR160W/Srs2 antibodies requires multiple complementary approaches to ensure experimental reliability:

Genetic Controls:

• Test antibodies in wild-type strains versus srs2 deletion strains

• A specific antibody should show signal in wild-type but not in deletion strains

Expression Level Controls:

• Use strains with overexpressed SRS2 (e.g., under the CUP1 promoter)

• Confirm increased signal intensity with higher protein levels

• Include concentration gradients to verify proportional signal response

Epitope-Tagged Controls:

• Compare antibody reactivity in strains expressing tagged versions (e.g., Myc-tagged Srs2)

• Detect with both anti-Srs2 and anti-tag antibodies to confirm co-localization

• The search results mention constructs with tagged versions that can be used for validation

Mutant Analysis:

• Test antibody recognition of helicase-dead mutants (srs2-K41A, srs2-K41R)

• This verifies that the antibody detects structural features rather than activity-dependent epitopes

Pre-absorption Controls:

• Pre-incubate antibody with recombinant Srs2 protein before immunodetection

• Specific signals should be eliminated or significantly reduced

These validation steps ensure that experimental observations truly reflect Srs2 biology rather than artifacts of non-specific antibody binding.

How can YGR160W antibodies be used to study helicase-independent functions of Srs2?

YGR160W/Srs2 antibodies are invaluable for investigating the helicase-independent functions of Srs2, which have proven to be significant as revealed in the search results:

Comparative Analysis with Helicase-Dead Mutants:

• Use antibodies to immunoprecipitate both wild-type Srs2 and helicase-dead mutants (srs2-K41A and srs2-K41R)

• The K41A mutant cannot bind ATP, while K41R can bind but not hydrolyze ATP

• Analyze and compare protein interaction partners to identify helicase-independent interactions

PCNA Interaction Studies:

• The search results indicate that Srs2 acts at replication forks independently of its helicase function, likely through recruitment by SUMOylated PCNA

• Use co-immunoprecipitation with Srs2 antibodies to detect PCNA interactions

• Compare wild-type with the srs2-R1 mutant that cannot interact with PCNA

Chromatin Association Analysis:

• Perform ChIP with anti-Srs2 antibodies to compare recruitment patterns of wild-type and helicase-dead Srs2 to chromatin

• This helps identify genomic regions where Srs2 functions without utilizing its helicase activity

Genetic Interaction Validation:

• The search results show that overexpression of both wild-type SRS2 and helicase-dead mutants resulted in similar genetic interactions

• Use antibodies to confirm expression levels in these genetic studies

• Validate physical interactions suggested by genetic data

This approach has revealed that Srs2's helicase-independent function "is responsible for the negative interactions with DNA metabolism genes and for the toxicity of SRS2" , representing a significant aspect of its biological role.

What experimental approaches effectively use YGR160W antibodies to investigate Srs2-PCNA interactions?

Several advanced experimental approaches using YGR160W/Srs2 antibodies can effectively characterize the crucial Srs2-PCNA interactions:

Co-Immunoprecipitation (Co-IP):

• Use anti-Srs2 antibodies to pull down complexes from cell lysates

• Analyze by Western blotting for PCNA to detect interaction

• Perform under various conditions: normal growth, replication stress, DNA damage

SUMOylation-Specific Analysis:

• Use sequential IP (first with anti-SUMO, then with anti-PCNA or vice versa)

• This enriches for SUMOylated PCNA

• Follow with anti-Srs2 Western blotting to specifically detect Srs2 bound to SUMOylated PCNA

Mutant Comparison Studies:

• Compare wild-type Srs2 with the srs2-R1 mutant that cannot interact with PCNA

• The search results indicate that "overexpression of srs2-R1 abolishes the replication defects" caused by Srs2 overexpression

• This approach isolates the specific effects of the Srs2-PCNA interaction

ChIP-Sequential IP (ChIP-seq):

• Perform ChIP with anti-PCNA antibodies

• Re-ChIP the PCNA-associated chromatin with anti-Srs2 antibodies

• Sequence the associated DNA to identify genomic loci where both proteins co-localize

Chromatin Spread Analysis:

• Use fluorescently labeled antibodies against both Srs2 and PCNA

• Analyze co-localization on chromatin spreads using fluorescence microscopy

• Quantify co-localization events in different cell cycle stages

These approaches have revealed that "Srs2 is recruited to replication forks by SUMOylated PCNA where it removes Rad51 filaments thus preventing homologous recombination during replication and favoring PRR [Post-Replication Repair]" .

How can researchers use YGR160W antibodies to distinguish between wild-type and mutant forms of Srs2?

Distinguishing between wild-type Srs2 and mutant forms requires strategic antibody-based approaches:

Domain-Specific Antibodies:

• Develop antibodies that specifically recognize the wild-type K41 region

• These antibodies would fail to recognize the mutated versions (K41A or K41R)

• Requires generating antibodies against peptides containing the wild-type sequence around position 41

Functional Assays Following IP:

• Immunoprecipitate Srs2 with a general anti-Srs2 antibody

• Perform helicase activity assays on the immunoprecipitated material

• Wild-type Srs2 will show activity, while K41A and K41R mutants will not

Differential Co-IP Analysis:

• Compare the interaction profiles of wild-type versus mutant Srs2

• Use antibodies to perform IP followed by mass spectrometry

• Identify interaction partners that differentially associate with wild-type versus mutant Srs2

Post-translational Modification Detection:

• Develop antibodies against specific post-translational modifications of Srs2

• Compare modification patterns between wild-type and mutant forms

• The search results mention phosphatase treatments which suggest phosphorylation analysis protocols

Expression Analysis in Transformed Strains:

• The search results describe plasmids expressing SRS2, srs2-K41A, and srs2-K41R under the CUP1 promoter

• Use antibodies to confirm expression levels of these constructs

• Monitor protein stability differences between wild-type and mutant forms

These approaches provide researchers with multiple methods to distinguish between functional wild-type Srs2 and its various mutant forms, enabling detailed mechanistic studies.

What are the optimal immunoprecipitation protocols for YGR160W antibodies?

Optimal immunoprecipitation (IP) protocols for YGR160W/Srs2 antibodies require careful attention to several key parameters:

Cell Growth and Lysis:

• Grow cells in appropriate selective media (SC-LEU for strains carrying LEU2-marked plasmids)

• For native protein extraction, dilute overnight cultures and allow a 2-hour growth period

• Use gentle lysis methods to preserve protein complexes and interactions

Buffer Composition Table:

Phosphatase Treatment (if studying phosphorylation):

• Incubate samples at 30°C with phosphatase buffer, MnCl2, phosphatase inhibitors, and lambda-phosphatase as described in the search results

• Run control samples without phosphatase for comparison

Antibody Selection and Amount:

• For IP of Srs2, use 2-5 μg of antibody per mg of protein lysate

• Pre-bound antibody-bead complexes often yield cleaner results than sequential addition

Incubation Conditions:

• Incubate overnight at 4°C with gentle rotation for optimal complex formation

• Shorter incubations (2-4 hours) may be sufficient for abundant epitopes

Elution Methods:

• For Western blot analysis: elute in SDS sample buffer

• For activity assays: use gentle elution with excess peptide or low pH

• For mass spectrometry: on-bead digestion often yields cleaner results

The search results provide specific details about protein extraction methods and buffer components that have been successfully used with Srs2 .

How can researchers troubleshoot weak signals when using YGR160W antibodies in Western blots?

When troubleshooting weak signals with YGR160W/Srs2 antibodies in Western blots, researchers should implement these strategic approaches:

Optimized Protein Extraction:

• Follow the NaOH/TCA precipitation method described in the search results:

  • 1.85 N NaOH with 7.5% 2-mercaptoethanol

  • Precipitate with 50% TCA

  • Resuspend in buffer with 8 M Urea and 5% SDS

• This harsh extraction method is particularly effective for nuclear proteins like Srs2

SDS-PAGE and Transfer Optimization:

• Use 6% gels specifically for visualizing Srs2 as mentioned in the search results

• Transfer at lower voltage (25V) for longer periods

• Consider adding 0.1% SDS to transfer buffer for large proteins

• Use PVDF membranes rather than nitrocellulose for stronger protein binding

Signal Enhancement Strategies:

• Increase antibody concentration (try 1:500 instead of 1:2000)

• Extend primary antibody incubation (overnight at 4°C)

• Use signal enhancement systems (biotin-streptavidin amplification)

• Try more sensitive ECL substrates designed for low-abundance proteins

Protein Enrichment Approaches:

• Use strains overexpressing Srs2 under the CUP1 promoter as described in the search results

• Induce expression with copper sulfate (50-200 μM CuSO4)

• Consider concentrating nuclear fractions where Srs2 is predominantly located

• Immunoprecipitate Srs2 before Western blotting to increase concentration

Blocking and Washing Optimization:

• Test different blocking agents (5% milk vs. 3% BSA)

• Reduce washing stringency if signal is weak

• Ensure antibody buffer contains 0.1% Tween-20 to reduce non-specific binding

These approaches have been demonstrated to be effective for detecting Srs2 in the research described in the search results, which specifically mentions gel percentages and transfer conditions optimized for this protein .

What buffer conditions optimize YGR160W antibody performance in chromatin immunoprecipitation (ChIP)?

Optimizing buffer conditions for YGR160W/Srs2 antibodies in ChIP experiments requires careful consideration of several key parameters:

Crosslinking Protocol:

• Use 1% formaldehyde for 15-20 minutes at room temperature

• Quench with glycine (125 mM final concentration)

• For transient DNA interactions characteristic of helicases like Srs2, shorter crosslinking times (10 minutes) may better preserve physiologically relevant interactions

Buffer Composition Table for ChIP:

Chromatin Preparation:

• Target chromatin fragments of 200-500 bp for optimal Srs2 detection

• Verify fragmentation by agarose gel electrophoresis

• Pre-clear chromatin with protein A/G beads to reduce background

Antibody Conditions:

• Use 3-5 μg of antibody per ChIP reaction

• Pre-bind antibodies to protein A/G beads for cleaner results

• Include IgG control reactions to assess non-specific binding

Washing Strategy:

• Implement sequential washes of increasing stringency

• Perform at least 3-5 washes with each buffer

• Maintain cold temperature (4°C) during washing steps

Controls to Include:

• Input samples (non-immunoprecipitated chromatin)

• No-antibody controls

• Ideally, perform ChIP in srs2 deletion strains as negative controls

When studying Srs2-PCNA interactions at replication forks, these optimized conditions will help capture the dynamic association of Srs2 with chromatin through its interaction with SUMOylated PCNA .

How can YGR160W antibodies help investigate the role of Srs2 in homologous recombination?

YGR160W/Srs2 antibodies provide powerful tools for investigating Srs2's crucial role in regulating homologous recombination (HR):

Rad51 Filament Disruption Studies:

• Use immunofluorescence with anti-Srs2 and anti-Rad51 antibodies to visualize their relationship in situ

• Perform sequential ChIP (Srs2 followed by Rad51) to identify genomic loci where Srs2 removes Rad51

• The search results highlight Srs2's role in dismantling Rad51 nucleoprotein filaments, which are required for homologous recombination

Recruitment Kinetics Analysis:

• Use ChIP with anti-Srs2 antibodies following DNA damage induction

• Analyze temporal recruitment patterns of Srs2 to damage sites

• Compare with recruitment of pro-recombination factors

PCNA-Mediated Regulation:

• The search results emphasize that "Srs2 is recruited to replication forks by SUMOylated PCNA where it removes Rad51 filaments"

• Use antibodies against Srs2, PCNA, and SUMO in co-IP experiments

• Analyze how this recruitment prevents inappropriate recombination during replication

Helicase-Independent Anti-Recombinase Function:

• Compare recruitment of wild-type and helicase-dead Srs2 mutants

• The search results note that "Srs2 acts as an anti-recombinase also independently of its recruitment to replication forks by PCNA"

• Use antibodies to elucidate these distinct mechanisms

Genetic Context Analysis:

• Use antibodies to compare Srs2 levels and localization in different genetic backgrounds

• The search results mention that Srs2 was identified as a suppressor of rad6 and rad18 mutations

• This approach helps clarify how Srs2 functions in different DNA repair contexts

These experimental approaches using YGR160W antibodies are essential for understanding the complex regulatory role of Srs2 in preventing inappropriate recombination while allowing necessary HR events to proceed.

What methodologies effectively analyze Srs2 post-translational modifications using YGR160W antibodies?

YGR160W/Srs2 antibodies can be employed in several sophisticated methodologies to analyze post-translational modifications (PTMs) that regulate Srs2 function:

Phosphorylation Analysis:

• The search results specifically describe phosphatase treatment protocols for analyzing Srs2

• Compare migration patterns of Srs2 before and after phosphatase treatment

• Sample processing protocol:

  • Incubate protein samples at 30°C with phosphatase buffer and MnCl2

  • Add phosphatase inhibitors in control samples

  • Add lambda-phosphatase to experimental samples

  • Stop reactions with SDS sample buffer

SUMOylation Detection Strategy:

• Perform immunoprecipitation with anti-Srs2 antibodies

• Analyze by Western blotting with anti-SUMO antibodies

• Include de-SUMOylation treatment controls (SENP/Ulp1)

• This approach is particularly relevant since Srs2 interacts with SUMOylated PCNA

Ubiquitination Analysis:

• Immunoprecipitate Srs2 under denaturing conditions

• Western blot with anti-ubiquitin antibodies

• Include proteasome inhibitor treatments to accumulate ubiquitinated forms

• This helps understand Srs2 regulation through protein stability control

Mass Spectrometry Workflow:

• Immunoprecipitate Srs2 using specific antibodies

• Separate by SDS-PAGE and excise bands

• Perform tryptic digestion

• Analyze by LC-MS/MS with PTM-specific settings

• Validate findings with PTM-specific antibodies if available

Cell Cycle-Dependent Modification Analysis:

• Synchronize yeast cultures (the search results mention alpha-factor arrest in G1)

• Collect samples at different cell cycle stages

• Analyze Srs2 modifications using antibodies

• Correlate with Srs2 function at different cell cycle phases

These methodologies enable researchers to understand how PTMs regulate Srs2's multiple functions in DNA metabolism, including its roles in "checkpoint activation, adaptation and recovery, and in resolution of late recombination intermediates" .

How can new YGR160W antibody development enhance single-molecule studies of Srs2?

Development of next-generation YGR160W/Srs2 antibodies could significantly advance single-molecule studies through these innovative approaches:

Fab Fragment Generation for Minimal Interference:

• Develop and validate Fab fragments from full IgG anti-Srs2 antibodies

• These smaller fragments minimize steric hindrance during single-molecule experiments

• They allow closer observation of Srs2's interaction with DNA substrates and protein partners

Domain-Specific Antibodies for Mechanistic Studies:

Antibody-Based FRET Systems:

• Develop fluorescently labeled anti-Srs2 antibodies for FRET experiments

• Pair with labeled DNA or partner proteins (e.g., PCNA, Rad51)

• This approach enables real-time tracking of conformational changes during Srs2 activity

High-Affinity Recombinant Antibodies:

• Engineer recombinant antibodies with enhanced specificity and affinity

• These can improve signal-to-noise ratio in single-molecule experiments

• Options include scFv (single-chain variable fragments) and nanobodies

Applications in Single-Molecule Techniques:

• Total Internal Reflection Fluorescence (TIRF) microscopy using fluorescent antibodies

• Optical or magnetic tweezers experiments with antibody-based detection

• DNA curtain assays to visualize Srs2 translocation and anti-recombinase activity

These advances would allow researchers to directly observe helicase-independent functions of Srs2 at replication forks, which the search results identify as occurring "likely through its recruitment by the sumoylated PCNA replication clamp" .

What strategies can improve YGR160W antibody applications in genome-wide studies?

Advanced strategies can significantly enhance YGR160W/Srs2 antibody applications in genome-wide studies:

ChIP-seq Optimization for Low-Abundance Factors:

• Develop enhanced ChIP protocols specifically for transient DNA-binding factors like Srs2

• Implement spike-in normalization with exogenous DNA and antibody controls

• This addresses the challenge of Srs2's dynamic association with chromatin

CUT&RUN/CUT&Tag Adaptation:

• Modify CUT&RUN or CUT&Tag protocols for use with anti-Srs2 antibodies

• These techniques offer higher sensitivity than traditional ChIP

• Particularly valuable for detecting Srs2 at specific genomic loci during replication

Sequential ChIP-seq for Interaction Mapping:

• First ChIP with anti-PCNA antibodies

• Re-ChIP with anti-Srs2 antibodies

• This specifically maps genomic regions where Srs2 is recruited by PCNA

• Compare wild-type with the srs2-R1 mutant that cannot interact with PCNA

Integration with Replication Timing Data:

• Combine Srs2 ChIP-seq with replication timing analyses

• Correlate Srs2 binding with early/late replication regions

• This helps understand Srs2's role in preventing recombination during replication

Chromatin Proteomics Approaches:

• Use Srs2 antibodies for Chromatin Immunoprecipitation followed by Mass Spectrometry (ChIP-MS)

• Identify proteins co-occurring with Srs2 at specific genomic loci

• Compare protein cohorts between normal and DNA damage conditions

Single-Cell Applications:

• Adapt antibody-based techniques for single-cell analyses

• Develop protocols for single-cell CUT&Tag with Srs2 antibodies

• This reveals cell-to-cell variation in Srs2 chromatin association

These genome-wide approaches would provide valuable insights into how Srs2 functions "in checkpoint activation, adaptation and recovery, and in resolution of late recombination intermediates" across the entire genome.